Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.03 -0.18 (-1.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Return on Equity [ROE] (2019 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) recorded Return on Equity [ROE] of -52.45% in Q2 2026, down 26.56 percentage points from -25.89% a year earlier and down 12.66 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Arcturus Therapeutics Holdings reported Return on Equity [ROE] of -28.92%, up 2.24 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of +4.95 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -31.16% in FY2024 (-20.33 pp), -10.83% in FY2023 (-14.58 pp), 3.75% in FY2022 (+68.95 pp) and -65.20% in FY2021 (-31.33 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q3 2022.
  • On a year-over-year basis, Return on Equity [ROE] rose in three of the last eight quarters, with an average year-over-year change of -13.67 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 132.69 percentage points in Q1 2023, against a drop of 77.12 percentage points in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -39.79% (Q1 2026), -30.00% (Q4 2025) and -29.28% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Arcturus Therapeutics Holdings 370.35 Mn -443.78 Mn - -52.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.45%
Mar 31, 2026 -39.79%
Dec 31, 2025 -30.00%
Sep 30, 2025 -29.28%
Jun 30, 2025 -25.89%
Mar 31, 2025 -28.71%
Dec 31, 2024 -32.19%
Sep 30, 2024 -24.06%
Jun 30, 2024 -27.53%
Mar 31, 2024 -39.57%
Dec 31, 2023 -10.64%
Sep 30, 2023 35.59%
Jun 30, 2023 26.55%
Mar 31, 2023 37.55%
Dec 31, 2022 5.07%
Sep 30, 2022 -92.13%
Jun 30, 2022 -92.44%
Mar 31, 2022 -95.14%
Dec 31, 2021 -83.25%
Sep 30, 2021 -69.51%
API Access

Arcturus Therapeutics Holdings Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARCT&period=max&api_key=YOUR_API_KEY